141 related articles for article (PubMed ID: 16907919)
1. Ablation of ovomucoid-induced allergic response by desensitization with recombinant ovomucoid third domain in a murine model.
Rupa P; Mine Y
Clin Exp Immunol; 2006 Sep; 145(3):493-501. PubMed ID: 16907919
[TBL] [Abstract][Full Text] [Related]
2. Engineered recombinant ovomucoid third domain can desensitize Balb/c mice of egg allergy.
Rupa P; Mine Y
Allergy; 2006 Jul; 61(7):836-42. PubMed ID: 16792581
[TBL] [Abstract][Full Text] [Related]
3. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.
Rupa P; Mine Y
Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843
[TBL] [Abstract][Full Text] [Related]
4. Genetically glycosylated ovomucoid third domain can modulate Immunoglobulin E antibody production and cytokine response in BALB/c mice.
Rupa P; Nakamura S; Mine Y
Clin Exp Allergy; 2007 Jun; 37(6):918-28. PubMed ID: 17517106
[TBL] [Abstract][Full Text] [Related]
5. The recombinant major allergen of Parietaria judaica and its hypoallergenic variant: in vivo evaluation in a murine model of allergic sensitization.
Orlandi A; Grasso F; Corinti S; Marinaro M; Bonura A; Boirivant M; Colombo P; Di Felice G
Clin Exp Allergy; 2004 Mar; 34(3):470-7. PubMed ID: 15005743
[TBL] [Abstract][Full Text] [Related]
6. Oral immunotherapy with immunodominant T-cell epitope peptides alleviates allergic reactions in a Balb/c mouse model of egg allergy.
Rupa P; Mine Y
Allergy; 2012 Jan; 67(1):74-82. PubMed ID: 21950267
[TBL] [Abstract][Full Text] [Related]
7. Novel B and T cell epitopes of chicken ovomucoid (Gal d 1) induce T cell secretion of IL-6, IL-13, and IFN-gamma.
Holen E; Bolann B; Elsayed S
Clin Exp Allergy; 2001 Jun; 31(6):952-64. PubMed ID: 11422162
[TBL] [Abstract][Full Text] [Related]
8. Intake of Diet Including 1% Ovomucoid for 4 Weeks Induces Oral Desensitization in Ovomucoid-Specific Allergic Mouse Model.
Maeta A; Sakamoto Y; Yuki S; Takahashi K
J Nutr Sci Vitaminol (Tokyo); 2017; 63(2):104-110. PubMed ID: 28552874
[TBL] [Abstract][Full Text] [Related]
9. Genetic attachment of undecane peptides to ovomucoid third domain can suppress the production of specific IgG and IgE antibodies.
Mine Y; Rupa P
Biochem Biophys Res Commun; 2003 Nov; 311(1):223-8. PubMed ID: 14575717
[TBL] [Abstract][Full Text] [Related]
10.
Li J; Yang L; Wang J; Yang Y; Wu Y; Jiang Q; Yang Y; Ma D; Zhang R; Huang N; Li W; Liu G; Zhu R
J Immunol; 2019 Jul; 203(1):31-38. PubMed ID: 31092638
[No Abstract] [Full Text] [Related]
11. Rush Oral Immunotherapy Does Not Reduce Allergic Response in Mice with Mild Allergy to Egg White Ovomucoid.
Maeta A; Kaji M; Nagaishi M; Hirakawa A; Takahashi K
J Nutr Sci Vitaminol (Tokyo); 2015; 61(5):400-5. PubMed ID: 26639848
[TBL] [Abstract][Full Text] [Related]
12. A mouse model of mosquito allergy for study of antigen-specific IgE and IgG subclass responses, lymphocyte proliferation, and IL-4 and IFN-gamma production.
Chen YL; Simons FE; Peng Z
Int Arch Allergy Immunol; 1998 Aug; 116(4):269-77. PubMed ID: 9693276
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of mice with olive pollen allergen Ole e 1 induces a Th2 response.
Batanero E; Barral P; Villalba M; RodrÃguez R
Int Arch Allergy Immunol; 2002 Apr; 127(4):269-75. PubMed ID: 12021545
[TBL] [Abstract][Full Text] [Related]
14. Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy.
Freidl R; Gstoettner A; Baranyi U; Swoboda I; Stolz F; Focke-Tejkl M; Wekerle T; van Ree R; Valenta R; Linhart B
J Allergy Clin Immunol; 2017 Jun; 139(6):1897-1905.e1. PubMed ID: 27876628
[TBL] [Abstract][Full Text] [Related]
15. T cell epitope immunotherapy ameliorates allergic responses in a murine model of shrimp allergy.
Wai CY; Leung NY; Leung PS; Chu KH
Clin Exp Allergy; 2016 Mar; 46(3):491-503. PubMed ID: 26610061
[TBL] [Abstract][Full Text] [Related]
16. Rush desensitization with a single antigen induces subclinical activation of mast cells and protects against bystander challenge in dually sensitized mice.
Killoran KE; Kropp LE; Lindrose AR; Curtis HE; Cook D; Mitre E
Clin Exp Allergy; 2019 Apr; 49(4):484-494. PubMed ID: 30506823
[TBL] [Abstract][Full Text] [Related]
17. Design and evaluation of a hypoallergenic peptide-based vaccine for Salsola kali allergy.
Tabesh S; Fanuel S; Fazlollahi MR; Yekaninejad MS; Kardar GA; Razavi SA
Int Immunopharmacol; 2019 Jan; 66():62-68. PubMed ID: 30445308
[TBL] [Abstract][Full Text] [Related]
18. Quillaja saponin can modulate ovalbumin-induced IgE allergic responses through regulation of Th1/Th2 balance in a murine model.
Katayama S; Mine Y
J Agric Food Chem; 2006 May; 54(9):3271-6. PubMed ID: 16637684
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy with a recombinant hybrid molecule alleviates allergic responses more efficiently than an allergenic cocktail or pollen extract in a model of chenopodium album allergy.
Nouri HR; Sankian M; Afsharzadeh D; Varasteh A
Int Arch Allergy Immunol; 2013; 161(4):325-32. PubMed ID: 23689669
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy.
Corthésy B; Lassus A; Terrettaz J; Tranquart F; Bioley G
Allergy; 2016 Jul; 71(7):957-66. PubMed ID: 26850222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
